The invention as disclosed herein is a method and composition for the
treatment of HIV in humans and other host animals, that includes the
administration of an effective HIV treatment amount of a phenylindole as
described herein or a pharmaceutically acceptable salt or prodrug thereof,
optionally in a pharmaceutically acceptable carrier. The compounds of this
invention either possess antiviral (i.e., anti-HIV) activity, or are
metabolized to a compound that exhibits such activity.
